Brazil’s medicinal cannabis market is evolving rapidly, with more patients, new regulatory pathways, and a growing industry presence.

But how accessible are these treatments, and what are the biggest challenges companies face?

In this episode of International Pharma Talks, Dr. Diogo Sousa-Martins explores the business and regulatory landscape of medicinal cannabis in Brazil.

From market trends to future policy changes, we’ll break down what’s shaping this fast-moving sector.

You’ll learn more about:

• The surge in patient numbers and what it means for market growth
• Regulatory frameworks for cannabis-based treatments and their challenges
• Why official drug registrations remain rare despite existing pathways
• The impact of Anvisa’s upcoming regulatory agenda on the industry

With Brazil poised to become a key player in Latin America's cannabis market, understanding these developments is crucial. Tune in now to stay ahead of the curve.

Learn more at els-solutions.com.

"This episode was recorded in 2024. As such, some of the data discussed may have changed. This podcast has been prepared from different bibliographic sources. The opinions and comments conveyed therein are based on previous corporate experiences of ELS members, in addition to the references listed."